The burden of multiple sclerosis in China: A literature review
- Author:
Shanlian Hu
;
Prina Donga
;
Gemma Zhu
;
Feng Pan
;
Cheng Wang
- Publication Type:Journal Article
- From:Neurology Asia
2011;16(3):187-193
- CountryMalaysia
- Language:English
-
Abstract:
Background & Objective: Multiple sclerosis is a relatively rare disease in China as compared to other
nations throughout the world. This study aimed to assess the depth and breadth of knowledge of
multiple sclerosis and its consequences specifi cally in China via a review and synthesis of existing
literature. Methods: We conducted a literature search and reviewed studies that either were published in
MEDLINE-indexed, English-language journals, or China National Knowledge Infrastructure databaseindexed,
Chongqing VIP Information Co., Ltd database-indexed, or Wanfang Data database-indexed
Chinese-language journals, or appeared in the grey literature including medical society websites and
scientifi c meeting abstracts from 2005−2010. Results: The only study reporting epidemiological burden
reported a prevalence rate of multiple sclerosis to be 1.39 per 100,000 persons. Multiple sclerosis was
more prevalent among females as compared to males. Most of the studies used Poser criteria to
diagnose multiple sclerosis. Corticosteroids were the mainstay used by physicians for the treatment
of multiple sclerosis. Little data is available on epidemiological burden and no data is available on
the economic and humanistic burden of multiple sclerosis in China.
Conclusions: Diagnostic practices and treatment of multiple sclerosis in China appear to lag behind
those in Western countries. There is signifi cant room for improvement in bettering those suffering
from multiple sclerosis in China.
- Full text:P020150805579380388308.pdf
